Finally, hyperglycemia influences the chemoresistance in various cancers via multiple modalities, such as the upregulation of insulin-like growth factor binding protein-2 (IGFBP-2) in breast cancer [88] and the SMAD3 and MYC phosphorylation in colorectal cancer [89]. The gene discussed is IGFBP2; the disease is Hyperglycemia.